Biomarkers and Biosimilars in Diabetes

Biosimilars are biological medical products/molecules which are almost identical copies of an original product manufactured by different companies and an already FDA-approved biological product, referred to as a reference product.  Human bio monitoring (HBM) is a tool of health-related environmental monitoring.

Diabetes is a major lifestyle disease, It is necessary to identify potential biomarkers associated with diabetes for early detection and proper management of diabetes.  Biomarkers are known as signature molecules or molecular markers or biological molecules found in blood, tissues and other body fluids. Biomarkers are used to monitor how well the body is responding to a particular disease. Hemoglobin A1c is considered as a biomarker for the presence of Diabetes Mellitus biosimilars in diabetes.

  • Scope and Role of Biomarkers
  • Biomarker Application in diabetes research
  • Novel Biomarkers
  • Biosimilar Development, Review, and Approval
  • Biosimilar and Interchangeable Products
  • Prescribing Biosimilar and Interchangeable Products
  • Biosimilar Product Information

Related Conference of Biomarkers and Biosimilars in Diabetes

February 21-22, 2022

2nd World Summit on Diabetes

Prague, Czech Republic
March 14-15, 2022

European Endocrinology and Diabetes Congress

Paris, France
March 14-15, 2022

World Congress on Endocrine and Diabetes

Paris, France
March 16-17, 2022

31st European Diabetes Congress

London, UK
March 17-18, 2022

3rd Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
March 21-22, 2022

4th Annual Conference on Diabetes and Endocrinology

Paris, France
April 20-21, 2022

Diabetes 2022

Toronto, Canada
April 25-26, 2022

3rd Asia Pacific Diabetes and Endocrinology Congress

Singapore City, Singapore
April 27-28, 2022

3rd Asia Pacific Endocrinology Congress

Toronto, Canada
May 10-11, 2022

World congress on Endocrinology and Metabolic syndrome

Auckland, Newzealand
May 27-28, 2022

International Endocrinology Congress

Rome, Italy
May 27-28, 2022

3rd World Summit on Diabetes Expo

Vancouver, Canada
July 06-07, 2022

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
July 20-21, 2022

5th International conference on Diabetic complications

Bangkok, Thailand
August 08-09, 2022

31st World Diabetes & Heart Congress

Tokyo, Japan
August 22-23, 2022

Global Meeting on Diabetes and Nursing Care

Prague, Czech Republic
September 19-20, 2022

4th International Conference on Cell Metabolism

Amsterdam, Netherlands
September 27-28, 2022

2nd Annual Summit on Diabetes and Endocrinology

Rome, Italy
September 28-29, 2022

16th European Diabetes and Endocrinology Congress

Rome, Italy
November 16-17, 2022

World congress and Expo on Diabetes

Manila, Philippines
November 22-23, 2022

18th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 28-29, 2022

International Conference on Diabetes & Heart Diseases

Yokohama, Japan
November 28-29, 2022

14th World Congress on Endocrinology and Metabolic Disorders

Sydney, Australia
December 08-09, 2022

5th Global Meeting on Diabetes and Endocrinology

Rome, Italy

Biomarkers and Biosimilars in Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in